Free provider profile
DAVID BOGUSLAVSKY, MD
Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2009-07-16.
757 ROUTE 202/206, BRIDGEWATER, NJ, 08807
908-754-5901
Single practice location
Enumerated 2006-12-19
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — 2 taxonomies listed — broader service mix.
- — Record last updated 17 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
1,124
Medicare patients
135
Part D drug cost
$325,404
Brand-name share
Not published
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Spravato (Esketamine Hcl) | 150 | $227,736 |
| Ozempic (Semaglutide) | 14 | $19,975 |
| Eliquis (Apixaban) | 15 | $13,102 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | 11 | $7,425 |
| Morphine Sulfate Er (Morphine Sulfate) | 18 | $782 |
| Levothyroxine Sodium (Levothyroxine Sodium) | 61 | $629 |
| Losartan Potassium (Losartan Potassium) | 55 | $500 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | 18 | $449 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
20241,214 sessions · 39 patients · $1,187,074
2023842 sessions · 28 patients · $912,751
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.